Tellgen Corporation

Short Term Long Term Short Term Comparison Long Term Comparison
  • 300642
  • 1d-5.78%
  • 1w-4.87%
  • 1m-6.87%
  • 1y-47.13%
ATH
  • ATH Price$46.72
  • ATH Date2021-06-29
  • % since ATH-72.43%
  • % to ATH262.71%
ATL
  • ATL Price$10.60
  • ATL Date2024-02-07
  • % from ATL21.51%
  • Last Low Price$10.6
  • Last Low Date2024-02-07
  • % From Last Low21.51%
IPO
  • IPO Price$47.65
  • % Current ROI USD-72.97%
  • ATH Price$46.72
  • % ROI ATH 44,072.74%
[addtoany]

Graph takes few seconds to load...

[financial_chart symbol="300642"]

Key Data [addtoany]

Current price $12.88
Sector Healthcare
Industry Medical Devices
Today's High/Low $13.98/$12.62
Volume 2,562,550.00
Previous Close $13.67
52 Week High/Low $24.0543/$9.94
Market Cap 2,243,602,432.00
P/E Ratio 27.898
Forward P/E 1 Yr. $0.00
Earnings Per Share(EPS) $0
Annualized Dividend $0.0146
$12.88
[addtoany]

Tellgen Corporation researches and develops, manufactures, and distributes IVDs in China and internationally.
It offers tumor markers, human papilloma virus test kits, ToRCH products, Y chromosome microdeletions test kits, and multiplex immunoassay systems.
The company was founded in 2003 and is based in Shanghai, China.

Annual Data | Millions of US $ except per share data
Cash on hand
Receivables
Inventory
Pre-Paid Expenses
Other Current Assets
Total Current Assets
Property, Plant, And Equipment
Long-Term Investments
Goodwill And Intangible Assets
Other Long-Term Assets
Total Long-Term Assets
Total Assets
Total Current Liabilities
Long Term Debt
Other Non-Current Liabilities
Total Long Term Liabilities
Total Liabilities
Common Stock Net
Retained Earnings (Accumulated Deficit)
Comprehensive Income
Other Share Holders Equity
Share Holder Equity
Total Liabilities And Share Holders Equity